|
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 37978951 | Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. | J Clin Oncol | 2024 |
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 37978951 | Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial. | J Clin Oncol | 2024 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 36107223 | MRI-guided laser interstitial thermal therapy for deep-seated gliomas in children with neurofibromatosis type 1: report of two cases. | Childs Nerv Syst | 2023 |
| 36335802 | The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. | Neoplasia | 2023 |
| 37628386 | Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group. | Children (Basel) | 2023 |
| 36521378 | Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach. | Neoplasia | 2023 |
| 36548930 | Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. | J Clin Oncol | 2023 |
| 37501569 | The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta-analysis. | Pediatr Blood Cancer | 2023 |
| 37628386 | Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group. | Children (Basel) | 2023 |
| 37501569 | The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta-analysis. | Pediatr Blood Cancer | 2023 |
| 36521378 | Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach. | Neoplasia | 2023 |
| 36548930 | Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. | J Clin Oncol | 2023 |
| 36107223 | MRI-guided laser interstitial thermal therapy for deep-seated gliomas in children with neurofibromatosis type 1: report of two cases. | Childs Nerv Syst | 2023 |
| 33948723 | Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature. | Childs Nerv Syst | 2022 |
| 35395680 | Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). | Neuro Oncol | 2022 |
| 35686831 | Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome. | Pediatr Blood Cancer | 2022 |
| 36590576 | An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. | Heliyon | 2022 |
| 36509072 | Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 33948723 | Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature. | Childs Nerv Syst | 2022 |
| 34558189 | Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors. | Pediatr Blood Cancer | 2022 |
| 35395680 | Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). | Neuro Oncol | 2022 |
| 35686831 | Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome. | Pediatr Blood Cancer | 2022 |
| 36590576 | An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. | Heliyon | 2022 |
| 36509072 | Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 34558189 | Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors. | Pediatr Blood Cancer | 2022 |
| 34125480 | Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. | Pediatr Blood Cancer | 2021 |
| 34125480 | Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. | Pediatr Blood Cancer | 2021 |
| 33838625 | Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. | N Engl J Med | 2021 |
| 34863095 | Discovery of clinically relevant fusions in pediatric cancer. | BMC Genomics | 2021 |
| 34895332 | Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas. | Acta Neuropathol Commun | 2021 |
| 33838625 | Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas. | N Engl J Med | 2021 |
| 34895332 | Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas. | Acta Neuropathol Commun | 2021 |
| 34863095 | Discovery of clinically relevant fusions in pediatric cancer. | BMC Genomics | 2021 |
| 32402552 | Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children. | Pediatr Neurol | 2020 |
| 32187454 | Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. | Pediatr Blood Cancer | 2020 |
| 32402552 | Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children. | Pediatr Neurol | 2020 |
| 32297094 | Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature. | J Neurooncol | 2020 |
| 32187454 | Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. | Pediatr Blood Cancer | 2020 |
| 32297094 | Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature. | J Neurooncol | 2020 |
| 30767415 | Critical review of the management of primary central nervous nongerminomatous germ cell tumors. | Pediatr Blood Cancer | 2019 |
| 31626289 | GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors. | J Neuropathol Exp Neurol | 2019 |
| 30767415 | Critical review of the management of primary central nervous nongerminomatous germ cell tumors. | Pediatr Blood Cancer | 2019 |
| 31235364 | The Risk of Developing Secondary Central Nervous System Tumors After Diagnostic Irradiation From Computed Tomography in Pediatrics: A Literature Review. | Pediatr Neurol | 2019 |
| 31195167 | Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. | Eur J Med Genet | 2019 |
| 31235364 | The Risk of Developing Secondary Central Nervous System Tumors After Diagnostic Irradiation From Computed Tomography in Pediatrics: A Literature Review. | Pediatr Neurol | 2019 |
| 31626289 | GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors. | J Neuropathol Exp Neurol | 2019 |
| 31195167 | Expanding the clinical history associated with syndromic Klippel-Feil: A unique case of comorbidity with medulloblastoma. | Eur J Med Genet | 2019 |